Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000148

Chairperson & CEO sold 9,500 shares at an average $491.57 ($4,669,918)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

13 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-23 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-23 Sale : show line 2 in the form 10b5-1 −2,388 $488.70 $1,167,007 331,555 I
2026-09-23 Sale : show line 3 in the form 10b5-1 −2,162 $489.52 $1,058,351 329,393 I
2026-09-23 Sale : show line 4 in the form 10b5-1 −1,440 $490.48 $706,286 327,953 I
2026-09-23 Sale : show line 5 in the form 10b5-1 −824 $491.65 $405,124 327,129 I
2026-09-23 Sale : show line 6 in the form 10b5-1 −480 $492.54 $236,421 326,649 I
2026-09-23 Sale : show line 7 in the form 10b5-1 −160 $493.72 $78,996 326,489 I
2026-09-23 Sale : show line 8 in the form 10b5-1 −155 $495.17 $76,752 326,334 I
Open-market sales · 9,500 sh · avg $491.57 · $4,669,918

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-23 Exercise or conversion : show line 14 in the form 10b5-1 Stock Option −9,500 375,910 I
Loading xslF345X06/primarydocument.xml…